Owlstone Medical, the innovative company which promises to revolutionise the diagnosis of cancer by simply analysing a patient's breath, has been given a major funding boost. Based in Cambridge, UK, the company has just raised $15 million (£11 mil...
Original Article: Breath Biopsy company adds new investor to $15m fundraising